ArticleEuropean journal of clinical investigation2016

The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.

Helen H Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.